Published in Mol Cancer Ther on June 22, 2010
Endophilin marks and controls a clathrin-independent endocytic pathway. Nature (2014) 1.69
Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. J Cell Biol (2012) 1.65
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev (2012) 1.61
Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion. Oncogene (2011) 1.18
Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (2013) 1.14
Mitotic moonlighting functions for membrane trafficking proteins. Traffic (2011) 1.06
Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. Oncogene (2011) 1.01
Dynamin inhibitors impair endocytosis and mitogenic signaling of PDGF. Traffic (2013) 0.86
Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease. Cold Spring Harb Perspect Biol (2014) 0.84
Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression. Mol Cancer (2011) 0.82
Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells. Mol Cancer (2013) 0.82
Protein adaptation: mitotic functions for membrane trafficking proteins. Nat Rev Mol Cell Biol (2013) 0.81
IQGAP1 is associated with nuclear envelope reformation and completion of abscission. Cell Cycle (2015) 0.79
The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Med (2013) 0.79
Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING. J Biol Chem (2016) 0.78
Different dynamin blockers interfere with distinct phases of synaptic endocytosis during stimulation in motoneurones. J Physiol (2015) 0.77
Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma. Am J Cancer Res (2015) 0.77
Sorting nexin 9 recruits clathrin heavy chain to the mitotic spindle for chromosome alignment and segregation. PLoS One (2013) 0.76
Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia. Sci Rep (2016) 0.75
Protein composition of catalytically active human telomerase from immortal cells. Science (2007) 3.53
Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol (2003) 3.11
Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell (2011) 2.56
Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell (2005) 2.40
A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc (2008) 2.02
Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Nat Neurosci (2006) 1.99
SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics (2007) 1.98
Involvement of novel autophosphorylation sites in ATM activation. EMBO J (2006) 1.94
Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol (2010) 1.84
The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci (2009) 1.73
Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorg Med Chem Lett (2004) 1.67
Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation. Bioorg Med Chem (2007) 1.63
Cystic fibrosis in Australia, 2009: results from a data registry. Med J Aust (2011) 1.53
Label-free quantitation of phosphopeptide changes during rat sperm capacitation. J Proteome Res (2010) 1.49
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem (2002) 1.44
YB-1: oncoprotein, prognostic marker and therapeutic target? Biochem J (2013) 1.38
Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles. Nat Neurosci (2010) 1.33
Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. Mol Pharmacol (2007) 1.33
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles. J Med Chem (2009) 1.30
Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem (2011) 1.27
Syndapin I and endophilin I bind overlapping proline-rich regions of dynamin I: role in synaptic vesicle endocytosis. J Neurochem (2007) 1.19
Synapsin I-associated phosphatidylinositol 3-kinase mediates synaptic vesicle delivery to the readily releasable pool. J Biol Chem (2003) 1.18
Mammalian septins nomenclature. Mol Biol Cell (2002) 1.16
Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity. Mol Cancer Ther (2005) 1.15
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motif. J Biol Chem (2004) 1.15
Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (2013) 1.14
Improved detection of hydrophilic phosphopeptides using graphite powder microcolumns and mass spectrometry: evidence for in vivo doubly phosphorylated dynamin I and dynamin III. Mol Cell Proteomics (2004) 1.13
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents. Curr Pharm Des (2004) 1.12
Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi. Org Biomol Chem (2010) 1.12
Protein-protein interactions identified by pull-down experiments and mass spectrometry. Curr Protoc Cell Biol (2004) 1.12
Ral: mediator of membrane trafficking. Int J Biochem Cell Biol (2006) 1.12
A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog (2010) 1.11
Y-box factor YB1 controls p53 apoptotic function. Oncogene (2005) 1.08
Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition. ChemMedChem (2008) 1.08
Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia (2008) 1.07
Autophosphorylation and ATM activation: additional sites add to the complexity. J Biol Chem (2010) 1.07
The in vivo phosphorylation sites of rat brain dynamin I. J Biol Chem (2007) 1.07
Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. Bioorg Med Chem Lett (2007) 1.06
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform. Blood (2011) 1.05
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Res (2006) 1.05
Phosphorylation regulates copper-responsive trafficking of the Menkes copper transporting P-type ATPase. Int J Biochem Cell Biol (2009) 1.05
YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst (2011) 1.04
Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. J Neurochem (2004) 1.03
Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. J Cell Biol (2009) 1.01
Rapid purification of native dynamin I and colorimetric GTPase assay. Methods Enzymol (2005) 1.01
Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene (2003) 1.01
Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. Mol Cell Biol (2008) 1.00
The phosphorylation of p25/TPPP by LIM kinase 1 inhibits its ability to assemble microtubules. Exp Cell Res (2007) 0.99
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res (2013) 0.99
PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma. Cancer Res (2008) 0.98
The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor. J Biol Chem (2003) 0.98
Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase. J Clin Endocrinol Metab (2002) 0.97
The mesenchymal architecture of the cranial mesoderm of mouse embryos is disrupted by the loss of Twist1 function. Dev Biol (2012) 0.97
Multisite phosphorylation of doublecortin by cyclin-dependent kinase 5. Biochem J (2004) 0.96
The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions. Oncogene (2003) 0.95
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity. Bioorg Med Chem Lett (2004) 0.95
Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nat Protoc (2012) 0.94
Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors. Trends Cell Biol (2012) 0.94
Calcineurin activity is required for the completion of cytokinesis. Cell Mol Life Sci (2010) 0.94
An FTIR spectroscopic study on the effect of molecular structural variations on the CO2 absorption characteristics of heterocyclic amines. Chemphyschem (2011) 0.93
Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells. Mol Cancer Ther (2011) 0.93
Kruppel-associated Box (KRAB)-associated co-repressor (KAP-1) Ser-473 phosphorylation regulates heterochromatin protein 1β (HP1-β) mobilization and DNA repair in heterochromatin. J Biol Chem (2012) 0.92
Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes. J Virol (2002) 0.92
Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder. Psychiatry Res (2010) 0.92
Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins. J Med Chem (2005) 0.91
Calcineurin selectively docks with the dynamin Ixb splice variant to regulate activity-dependent bulk endocytosis. J Biol Chem (2011) 0.91